Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2023 ▲▼ | Q1 2024 ▲▼ | Change ▲▼ | Q4 2023 ▲▼ | Q1 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Merus N V | 4,747,373 | 4,360,000 | -387,373 | $130.55M | $196.33M | 13.13% | +$65.78M |
| Vera Therapeutics, Inc.CL A(VERA) | 5,450,000 | 3,165,000 | -2,285,000 | $83.82M | $136.47M | 9.13% | +$52.65M |
| Nuvalent Inc | 1,331,037 | 1,487,756 | +156,719 | $97.95M | $111.72M | 7.47% | +$13.76M |
| Xenon Pharmaceuticals Inc.(XENE) | 2,167,793 | 2,167,793 | 0 | $99.85M | $93.32M | 6.24% | -$6.53M |
| Spyre Therapeutics, Inc.(SYRE) | 1,884,084 | 1,884,084 | 0 | $40.55M | $71.46M | 4.78% | +$30.92M |
| Enliven Therapeutics Inc | 2,901,816 | 3,973,245 | +1,071,429 | $40.16M | $69.89M | 4.67% | +$29.73M |
| Vaxcyte, Inc.(PCVX) | 1,100,000 | 860,000 | -240,000 | $69.08M | $58.75M | 3.93% | -$10.33M |
| Mind Medicine Mindmed Inc | 0 | 5,833,333 | +5,833,333 | $0 | $54.83M | 3.67% | +$54.83M |
| Alpine Immune Sciences Inc | 1,610,000 | 1,375,000 | -235,000 | $30.69M | $54.51M | 3.64% | +$23.82M |
| Arvinas, Inc.(ARVN) | 1,000,000 | 1,275,000 | +275,000 | $41.16M | $52.63M | 3.52% | +$11.47M |
| Rhythm Pharmaceuticals, Inc.(RYTM) | 1,550,000 | 1,050,000 | -500,000 | $71.25M | $45.50M | 3.04% | -$25.76M |
| Cogent Biosciences, Inc.(COGT) | 5,566,026 | 6,425,000 | +858,974 | $32.73M | $43.18M | 2.89% | +$10.45M |
| Pharvaris N V COM | 800,000 | 1,725,000 | +925,000 | $22.44M | $39.86M | 2.67% | +$17.42M |
| Celldex Therapeutics, Inc.(CLDX) | 701,967 | 866,468 | +164,501 | $27.84M | $36.37M | 2.43% | +$8.53M |
| Nkarta, Inc.(NKTX) | 2,730,000 | 3,165,000 | +435,000 | $18.02M | $34.21M | 2.29% | +$16.20M |
| Viridian Therapeutics, Inc.(VRDN) | 1,924,074 | 1,934,653 | +10,579 | $41.91M | $33.88M | 2.27% | -$8.03M |
| Celcuity Inc.(CELC) | 1,754,704 | 1,555,954 | -198,750 | $25.57M | $33.61M | 2.25% | +$8.04M |
| Kura Oncology, Inc.(KURA) | 1,248,062 | 1,525,000 | +276,938 | $17.95M | $32.53M | 2.18% | +$14.58M |
| C4 Therapeutics, Inc.(CCCC) | 3,800,000 | 3,410,384 | -389,616 | $21.47M | $27.86M | 1.86% | +$6.39M |
| ORIC Pharmaceuticals, Inc.(ORIC) | 0 | 2,000,000 | +2,000,000 | $0 | $27.50M | 1.84% | +$27.50M |
| ABIVAX Société AnonymeADS(ABVX) | 1,895,003 | 1,895,003 | 0 | $20.28M | $27.10M | 1.81% | +$6.82M |
| Perspective Therapeutics, Inc.(CATX) | 0 | 21,052,631 | +21,052,631 | $0 | $25.05M | 1.68% | +$25.05M |
| Immunovant, Inc.(IMVT) | 1,000,000 | 750,990 | -249,010 | $42.13M | $24.26M | 1.62% | -$17.87M |
| Kyverna Therapeutics, Inc.(KYTX) | 0 | 912,189 | +912,189 | $0 | $22.66M | 1.52% | +$22.66M |
| Engene Holdings Inc COM | 0 | 1,250,000 | +1,250,000 | $0 | $21.19M | 1.42% | +$21.19M |
| Apogee Therapeutics Inc | 250,000 | 290,000 | +40,000 | $6.99M | $19.27M | 1.29% | +$12.29M |
| Cabaletta Bio, Inc.(CABA) | 1,900,000 | 1,100,000 | -800,000 | $43.13M | $18.77M | 1.25% | -$24.36M |
| Autolus Therapeutics plcADS(AUTL) | 0 | 2,300,000 | +2,300,000 | $0 | $14.67M | 0.98% | +$14.67M |
| Third Harmonic Bio Inc | 706,706 | 1,250,000 | +543,294 | $7.75M | $11.80M | 0.79% | +$4.05M |
| Neurogene Inc.(NGNE) | 0 | 200,000 | +200,000 | $0 | $10.18M | 0.68% | +$10.18M |
| Adverum Biotechnologies Inc | 0 | 657,333 | +657,333 | $0 | $9.29M | 0.62% | +$9.29M |
| Vistagen Therapeutics, Inc.(VTGN) | 1,575,000 | 1,575,000 | 0 | $8.10M | $8.32M | 0.56% | +$220.5K |
| Syndax Pharmaceuticals, Inc.(SNDX) | 0 | 318,851 | +318,851 | $0 | $7.59M | 0.51% | +$7.59M |
| Soleno Therapeutics Inc | 700,000 | 169,533 | -530,467 | $28.18M | $7.26M | 0.49% | -$20.92M |
| Helix Acquisition Corp IiCL A | 0 | 500,000 | +500,000 | $0 | $5.20M | 0.35% | +$5.20M |
| MacroGenics, Inc.(MGNX) | 0 | 295,020 | +295,020 | $0 | $4.34M | 0.29% | +$4.34M |
| Adicet Bio Inc | 0 | 1,374,320 | +1,374,320 | $0 | $3.23M | 0.22% | +$3.23M |
| SAB Biotherapeutics, Inc.(SABS) | 1,831,746 | 183,174 | -1,648,572 | $1.26M | $831.6K | 0.06% | -$427.7K |
| Dbv Technologies S AADR | 92,687 | 92,687 | 0 | $88.3K | $69.4K | 0.00% | -$18.9K |
| Adverum Biotechnologies Inc | 10,000,000 | 0 | -10,000,000 | $7.53M | $0 | — | -$7.53M |
| Akero Therapeutics Inc | 565,000 | 0 | -565,000 | $13.19M | $0 | — | -$13.19M |
| Dyne Therapeutics, Inc.(DYN) | 900,000 | 0 | -900,000 | $11.97M | $0 | — | -$11.97M |
| Harpoon Therapeutics Inc | 1,500,000 | 0 | -1,500,000 | $17.05M | $0 | — | -$17.05M |
| Rayzebio Inc | 383,638 | 0 | -383,638 | $23.85M | $0 | — | -$23.85M |